Immunomodulators as an antimicrobial tool (Q36576318)

15 August 2017

1 reference

title

Immunomodulators as an antimicrobial tool (English)

1 reference

15 August 2017

2

Arturo Casadevall

1 reference

15 August 2017

1

Liise-anne Pirofski

1 reference

15 August 2017

22 August 2006

1 reference

Current Opinion in Microbiology

15 August 2017

1 reference

15 August 2017

9

1 reference

15 August 2017

489-495

1 reference

15 August 2017

5

1 reference

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults

15 August 2017

1 reference

12 December 2020

The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism

1 reference

12 December 2020

Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants

1 reference

12 December 2020

Fc gamma RIIB as a potential molecular target for intravenous gamma globulin therapy.

1 reference

12 December 2020

Cytokines and fungal infections

1 reference

12 December 2020

The third age of antimicrobial therapy

1 reference

12 December 2020

Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia

1 reference

12 December 2020

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

1 reference

12 December 2020

Trends in antimicrobial drug development: implications for the future

1 reference

12 December 2020

IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis

1 reference

12 December 2020

Prevention and treatment of respiratory syncytial virus infection in infants: an update

1 reference

12 December 2020

Steroids in adults with acute bacterial meningitis: a systematic review

1 reference

12 December 2020

Probiotics: immunomodulation and evaluation of safety and efficacy

1 reference

12 December 2020

A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens

1 reference

12 December 2020

The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis

1 reference

12 December 2020

Antibody-mediated regulation of cellular immunity and the inflammatory response

1 reference

12 December 2020

New concepts in antibody-mediated immunity

1 reference

12 December 2020

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

1 reference

12 December 2020

Serum therapy revisited: animal models of infection and development of passive antibody therapy

1 reference

12 December 2020

Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications

1 reference

12 December 2020

Established and emerging therapies for the treatment of viral hepatitis

1 reference

12 December 2020

Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis

1 reference

12 December 2020

Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response.

1 reference

12 December 2020

Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia

1 reference

12 December 2020

Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.

1 reference

12 December 2020

Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters

1 reference

12 December 2020

Probiotics: an emerging therapy.

1 reference

12 December 2020

Antibodies for defense against biological attack.

1 reference

12 December 2020

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

1 reference

12 December 2020

Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?

1 reference

12 December 2020

Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers

1 reference

12 December 2020

Antifungal antibodies: a new approach to the treatment of systemic candidiasis.

1 reference

12 December 2020

Treatment of acute myeloid leukemia with cytokines: effect on duration of neutropenia and response to infections.

1 reference

12 December 2020

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses

1 reference

12 December 2020

Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.

1 reference

12 December 2020

Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide

1 reference

12 December 2020

Towards a vaccine for Cryptococcus neoformans: principles and caveats.

1 reference

12 December 2020

Anti-inflammatory treatment of acute and chronic pneumonia

1 reference

12 December 2020

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90

1 reference

12 December 2020

Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae.

1 reference

12 December 2020

A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers

1 reference

12 December 2020

Malignancy: Granulocyte Colony Stimulating Factor Increases the Efficacy of Conventional Amphotericin in the Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients following Intensive Chemotherapy or Bone Marrow Transplantation f

1 reference

12 December 2020

Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model

1 reference

12 December 2020

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1 reference

12 December 2020

Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

The damage-response framework of microbial pathogenesis

1 reference

12 December 2020

Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis

1 reference

12 December 2020

INH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection

1 reference

12 December 2020

Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis

1 reference

12 December 2020

Immunoblot analysis of the serological response in systemic candidosis

1 reference

12 December 2020

Intravenous immunoglobulin for treating sepsis and septic shock

1 reference

12 December 2020

Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans

1 reference

12 December 2020

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group

1 reference

12 December 2020

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

1 reference

12 December 2020

10.1016/J.MIB.2006.08.004

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16931122